EA200001088A1 - Лечение общего тревожного состояния пароксетином - Google Patents
Лечение общего тревожного состояния пароксетиномInfo
- Publication number
- EA200001088A1 EA200001088A1 EA200001088A EA200001088A EA200001088A1 EA 200001088 A1 EA200001088 A1 EA 200001088A1 EA 200001088 A EA200001088 A EA 200001088A EA 200001088 A EA200001088 A EA 200001088A EA 200001088 A1 EA200001088 A1 EA 200001088A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- paroxetine
- treatment
- alarm condition
- general alarm
- solvate
- Prior art date
Links
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 title abstract 2
- AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 title abstract 2
- 229960002296 paroxetine Drugs 0.000 title abstract 2
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9808479.1A GB9808479D0 (en) | 1998-04-22 | 1998-04-22 | Method of treatment |
| PCT/US1999/008786 WO1999053919A1 (en) | 1998-04-22 | 1999-04-22 | Treatment of generalized anxiety disorder with paroxetine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA200001088A1 true EA200001088A1 (ru) | 2001-04-23 |
Family
ID=10830715
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200001088A EA200001088A1 (ru) | 1998-04-22 | 1999-04-22 | Лечение общего тревожного состояния пароксетином |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1073437A4 (cs) |
| JP (1) | JP2002512189A (cs) |
| KR (1) | KR20010034817A (cs) |
| CN (1) | CN1298301A (cs) |
| AP (1) | AP2000001959A0 (cs) |
| AU (1) | AU3864899A (cs) |
| BG (1) | BG104939A (cs) |
| BR (1) | BR9909791A (cs) |
| CA (1) | CA2328896A1 (cs) |
| CZ (1) | CZ20003885A3 (cs) |
| EA (1) | EA200001088A1 (cs) |
| GB (1) | GB9808479D0 (cs) |
| HU (1) | HUP0101350A3 (cs) |
| ID (1) | ID27546A (cs) |
| IL (1) | IL139167A0 (cs) |
| NO (1) | NO20005286L (cs) |
| PL (1) | PL343494A1 (cs) |
| SK (1) | SK15672000A3 (cs) |
| TR (1) | TR200003082T2 (cs) |
| WO (1) | WO1999053919A1 (cs) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2297550B (en) * | 1995-02-06 | 1997-04-09 | Smithkline Beecham Plc | Paroxetine hydrochloride anhydrate substantially free of bound organic solvent |
| GB9514842D0 (en) * | 1995-07-20 | 1995-09-20 | Smithkline Beecham Plc | Novel formulation |
-
1998
- 1998-04-22 GB GBGB9808479.1A patent/GB9808479D0/en not_active Ceased
-
1999
- 1999-04-22 HU HU0101350A patent/HUP0101350A3/hu unknown
- 1999-04-22 EP EP99921431A patent/EP1073437A4/en not_active Withdrawn
- 1999-04-22 ID IDW20002124A patent/ID27546A/id unknown
- 1999-04-22 TR TR2000/03082T patent/TR200003082T2/xx unknown
- 1999-04-22 AP APAP/P/2000/001959A patent/AP2000001959A0/en unknown
- 1999-04-22 JP JP2000544323A patent/JP2002512189A/ja not_active Withdrawn
- 1999-04-22 CZ CZ20003885A patent/CZ20003885A3/cs unknown
- 1999-04-22 BR BR9909791-5A patent/BR9909791A/pt not_active IP Right Cessation
- 1999-04-22 IL IL13916799A patent/IL139167A0/xx unknown
- 1999-04-22 KR KR1020007011729A patent/KR20010034817A/ko not_active Withdrawn
- 1999-04-22 PL PL99343494A patent/PL343494A1/xx not_active Application Discontinuation
- 1999-04-22 CA CA002328896A patent/CA2328896A1/en not_active Abandoned
- 1999-04-22 EA EA200001088A patent/EA200001088A1/ru unknown
- 1999-04-22 WO PCT/US1999/008786 patent/WO1999053919A1/en not_active Ceased
- 1999-04-22 CN CN99805328A patent/CN1298301A/zh active Pending
- 1999-04-22 SK SK1567-2000A patent/SK15672000A3/sk unknown
- 1999-04-22 AU AU38648/99A patent/AU3864899A/en not_active Abandoned
-
2000
- 2000-10-20 NO NO20005286A patent/NO20005286L/no not_active Application Discontinuation
- 2000-11-13 BG BG104939A patent/BG104939A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB9808479D0 (en) | 1998-06-17 |
| IL139167A0 (en) | 2001-11-25 |
| WO1999053919A1 (en) | 1999-10-28 |
| AP2000001959A0 (en) | 2000-12-31 |
| CZ20003885A3 (cs) | 2001-09-12 |
| NO20005286L (no) | 2000-12-20 |
| NO20005286D0 (no) | 2000-10-20 |
| HUP0101350A2 (hu) | 2002-05-29 |
| PL343494A1 (en) | 2001-08-27 |
| EP1073437A4 (en) | 2003-04-16 |
| ID27546A (id) | 2001-04-12 |
| SK15672000A3 (sk) | 2001-04-09 |
| KR20010034817A (ko) | 2001-04-25 |
| BG104939A (bg) | 2001-09-28 |
| EP1073437A1 (en) | 2001-02-07 |
| JP2002512189A (ja) | 2002-04-23 |
| AU3864899A (en) | 1999-11-08 |
| TR200003082T2 (tr) | 2001-01-22 |
| CA2328896A1 (en) | 1999-10-28 |
| BR9909791A (pt) | 2000-12-26 |
| CN1298301A (zh) | 2001-06-06 |
| HUP0101350A3 (en) | 2002-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE425253T1 (de) | Tribonektine | |
| EA200101116A1 (ru) | Способ лечения фиброза с помощью альфа-4-субъединицы антагониста интегрина | |
| EA199800667A1 (ru) | Новые фенантридины | |
| EA200100678A1 (ru) | N-уреидоалкил-пиперидины в качестве модуляторов активности рецепторов хемокинов | |
| EA200200194A1 (ru) | Антагонисты хемокинного рецептора и способы их применения | |
| EA200300503A1 (ru) | Новые лекарственные композиции на основе солей тиотропия и солей салметерола | |
| PT998287E (pt) | Utilizacao de levobupivacaina | |
| EA200101089A1 (ru) | Новый способ лечения | |
| NO20021035L (no) | Fremgangsmåter for anvendelse av rasktvirkende selective serotonin gjenopptakningsinhibitorer for behandling av seksuelldysfunksjon | |
| DE3786893D1 (de) | Piperidinderivat zur schmerzbehandlung. | |
| EA200200742A1 (ru) | 1,2-диарилбензимидазолы для лечения заболеваний, связанных с активацией микроглии | |
| FI953899A7 (fi) | Substituoituja atsolonijohdannaisia Helicobacterin aiheuttamien sairauksien hoitamiseksi | |
| DE60227283D1 (de) | Substituierte diketopiperazine als oxytocin-antagonisten | |
| PT935684E (pt) | Luva reforcada e metodo e aparelho para formar a mesma | |
| HUP0200152A2 (hu) | KQT1 csatornák gátlóinak alkalmazása parazita férgek és ektoparaziták által okozott betegségek kezelésére alkalmas gyógyszerkészítmények előállítására | |
| EA200100653A1 (ru) | Способ борьбы с членистоногими у животных | |
| TR199700956T1 (xx) | Indazolkarboksamidler. | |
| EA199800864A1 (ru) | Способ лечения при боли, вызванной мигренью | |
| EA199800866A1 (ru) | Способ снятия боли | |
| EA200000693A1 (ru) | Антагонисты хемокинного рецептора и способы их применения | |
| PT1237562E (pt) | Processo de preparacao de extractos de micania contendo micanolida e di-hidromicanolida e utilizacao no tratamento das doencas proliferativas | |
| EA200400692A1 (ru) | Антагонисты хемокинного рецептора и способы их применения | |
| EA199901061A1 (ru) | Новые соли врс-пептидов с органопротективной активностью, способ их получения и их использование в терапии | |
| EA200001088A1 (ru) | Лечение общего тревожного состояния пароксетином | |
| EA200100041A1 (ru) | Способ лечения |